Telmisartan Inhibits Non-Small Cell Lung Cancer by InducingFerroptosis through the NRF2/GPX4 Signaling Axis

20260 citationsJournal Article

Authors

Ling-Jie Wang · Qingdao University of Technology

Pengfei Guo · New Century International Hospital for Children

Sai Wang · New Century International Hospital for Children

Yizhao Chen · The First People's Hospital of Wenling

Hongwang Yan · The First People's Hospital of Wenling

Xue-Lin Zhang · The First People's Hospital of Wenling

Abstract

Telmisartan inhibited NSCLC by inducing ferroptosis via the NRF2/GPX4 axis, offering a new therapeutic strategy and potential clinical application for NSCLC treatment.

Topics & Keywords

Ferroptosis and cancer prognosis Cancer Mechanisms and Therapy Cancer, Stress, Anesthesia, and Immune Response

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Current Medicinal Chemistry

Volume 33

DOI: 10.2174/0109298673422337251024103233

Field-Weighted Citation Impact: 0.00